Everest Organics Limited (BOM:524790)
India · Delayed Price · Currency is INR 296.00
+5.65 (1.95%)
At close: Jul 27, 2026
Everest Organics Market Cap
Everest Organics has a market cap or net worth of 2.87 billion as of July 28, 2026. Its market cap has decreased by -13.13% in one year.
Market Cap
2.87B
Enterprise Value
3.37B
Revenue
1.97B
Ranking
n/a
PE Ratio
51.93
Stock Price
296.00
ChartMarket Cap Chart
Since January 4, 2002, Everest Organics's market cap has increased from 35.70M to 2.87B, an increase of 7,951.07%. That is a compound annual growth rate of 19.55%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 27, 2026 | 2.87B | -41.48% |
| Dec 31, 2025 | 4.91B | 103.94% |
| Dec 31, 2024 | 2.41B | 137.70% |
| Dec 29, 2023 | 1.01B | 2.68% |
| Dec 30, 2022 | 986.80M | -50.48% |
| Dec 31, 2021 | 1.99B | -10.33% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Albert David | 3.95B |
| BDH Industries | 3.40B |
| Medico Remedies | 3.17B |
| Trident Lifeline | 3.13B |
| Medicamen Biotech | 3.08B |
| Astonea Labs | 2.80B |
| Ambalal Sarabhai Enterprises | 2.49B |
| Gennex Laboratories | 2.21B |